Literature DB >> 29452352

Conditional ablation and conditional rescue models for Casq2 elucidate the role of development and of cell-type specific expression of Casq2 in the CPVT2 phenotype.

Daniel J Flores1, ThuyVy Duong1, Luke O Brandenberger1, Apratim Mitra1, Aditya Shirali1, John C Johnson1, Danielle Springer2, Audrey Noguchi2, Zu-Xi Yu3, Steven N Ebert4, Andreas Ludwig5, Bjorn C Knollmann6, Mark D Levin7, Karl Pfeifer1.   

Abstract

Cardiac calsequestrin (Casq2) associates with the ryanodine receptor 2 channel in the junctional sarcoplasmic reticulum to regulate Ca2+ release into the cytoplasm. Patients carrying mutations in CASQ2 display low resting heart rates under basal conditions and stress-induced polymorphic ventricular tachycardia (CPVT). In this study, we generate and characterize novel conditional deletion and conditional rescue mouse models to test the influence of developmental programs on the heart rate and CPVT phenotypes. We also compare the requirements for Casq2 function in the cardiac conduction system (CCS) and in working cardiomyocytes. Our study shows that the CPVT phenotype is dependent upon concurrent loss of Casq2 function in both the CCS and in working cardiomyocytes. Accordingly, restoration of Casq2 in only the CCS prevents CPVT. In addition, occurrence of CPVT is independent of the developmental history of Casq2-deficiency. In contrast, resting heart rate depends upon Casq2 gene activity only in the CCS and upon developmental history. Finally, our data support a model where low basal heart rate is a significant risk factor for CPVT.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29452352      PMCID: PMC5905597          DOI: 10.1093/hmg/ddy060

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  39 in total

1.  Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia.

Authors:  Todd J Herron; Michelle L Milstein; Justus Anumonwo; Silvia G Priori; José Jalife
Journal:  Heart Rhythm       Date:  2010-06-09       Impact factor: 6.343

2.  Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum.

Authors:  S Wang; W R Trumble; H Liao; C R Wesson; A K Dunker; C H Kang
Journal:  Nat Struct Biol       Date:  1998-06

Review 3.  Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Michela Faggioni; Dmytro O Kryshtal; Björn C Knollmann
Journal:  Pediatr Cardiol       Date:  2012-03-16       Impact factor: 1.655

4.  Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Björn C Knollmann; Nagesh Chopra; Thinn Hlaing; Brandy Akin; Tao Yang; Kristen Ettensohn; Barbara E C Knollmann; Kenneth D Horton; Neil J Weissman; Izabela Holinstat; Wei Zhang; Dan M Roden; Larry R Jones; Clara Franzini-Armstrong; Karl Pfeifer
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

5.  Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Alex V Postma; Isabelle Denjoy; Theo M Hoorntje; Jean-Marc Lupoglazoff; Antoine Da Costa; Pascale Sebillon; Marcel M A M Mannens; Arthur A M Wilde; Pascale Guicheney
Journal:  Circ Res       Date:  2002-10-18       Impact factor: 17.367

6.  Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.

Authors:  Dmitry Terentyev; Alessandra Nori; Massimo Santoro; Serge Viatchenko-Karpinski; Zuzana Kubalova; Inna Gyorke; Radmila Terentyeva; Srikanth Vedamoorthyrao; Nico A Blom; Giorgia Valle; Carlo Napolitano; Simon C Williams; Pompeo Volpe; Silvia G Priori; Sandor Gyorke
Journal:  Circ Res       Date:  2006-04-06       Impact factor: 17.367

7.  A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

Authors:  H Lahat; E Pras; T Olender; N Avidan; E Ben-Asher; O Man; E Levy-Nissenbaum; A Khoury; A Lorber; B Goldman; D Lancet; M Eldar
Journal:  Am J Hum Genet       Date:  2001-10-25       Impact factor: 11.025

8.  Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death.

Authors:  E R Behr; A Casey; M Sheppard; M Wright; T J Bowker; M J Davies; W J McKenna; D A Wood
Journal:  Heart       Date:  2007-01-19       Impact factor: 5.994

9.  Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.

Authors:  Norimichi Koitabashi; Djahida Bedja; Ari L Zaiman; Yigal M Pinto; Manling Zhang; Kathleen L Gabrielson; Eiki Takimoto; David A Kass
Journal:  Circ Res       Date:  2009-06-11       Impact factor: 17.367

10.  Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Marina Cerrone; Sami F Noujaim; Elena G Tolkacheva; Arkadzi Talkachou; Ryan O'Connell; Omer Berenfeld; Justus Anumonwo; Sandeep V Pandit; Karen Vikstrom; Carlo Napolitano; Silvia G Priori; José Jalife
Journal:  Circ Res       Date:  2007-09-13       Impact factor: 17.367

View more
  7 in total

1.  Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart Tissue.

Authors:  Sung-Jin Park; Donghui Zhang; Yan Qi; Yifei Li; Keel Yong Lee; Vassilios J Bezzerides; Pengcheng Yang; Shutao Xia; Sean L Kim; Xujie Liu; Fujian Lu; Francesco S Pasqualini; Patrick H Campbell; Judith Geva; Amy E Roberts; Andre G Kleber; Dominic J Abrams; William T Pu; Kevin Kit Parker
Journal:  Circulation       Date:  2019-07-17       Impact factor: 29.690

Review 2.  Animal Models to Study Cardiac Arrhythmias.

Authors:  Daniel J Blackwell; Jeffrey Schmeckpeper; Bjorn C Knollmann
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

Review 3.  Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Matthew J Wleklinski; Prince J Kannankeril; Bjӧrn C Knollmann
Journal:  J Physiol       Date:  2020-04-27       Impact factor: 5.182

4.  Bi-FoRe: an efficient bidirectional knockin strategy to generate pairwise conditional alleles with fluorescent indicators.

Authors:  Bingzhou Han; Yage Zhang; Xuetong Bi; Yang Zhou; Christopher J Krueger; Xinli Hu; Zuoyan Zhu; Xiangjun Tong; Bo Zhang
Journal:  Protein Cell       Date:  2020-07-17       Impact factor: 14.870

5.  The Purkinje-myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT.

Authors:  Daniel J Blackwell; Michela Faggioni; Matthew J Wleklinski; Nieves Gomez-Hurtado; Raghav Venkataraman; Chelsea E Gibbs; Franz J Baudenbacher; Shiaoching Gong; Glenn I Fishman; Patrick M Boyle; Karl Pfeifer; Bjorn C Knollmann
Journal:  JCI Insight       Date:  2022-02-08

6.  Association Study of Genetic Variants in Calcium Signaling-Related Genes With Cardiovascular Diseases.

Authors:  Sen Li; Zhaoqi Jia; Zhang Zhang; Yuxin Li; Meihui Yan; Tingting Yu
Journal:  Front Cell Dev Biol       Date:  2021-11-29

Review 7.  Calsequestrin, a key protein in striated muscle health and disease.

Authors:  Daniela Rossi; Alessandra Gamberucci; Enrico Pierantozzi; Caterina Amato; Loredana Migliore; Vincenzo Sorrentino
Journal:  J Muscle Res Cell Motil       Date:  2020-06-02       Impact factor: 2.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.